scholarly journals P30-3 Clinical experience of tumour lysis syndrome in patients with extensive disease small cell lung cancer

2021 ◽  
Vol 32 ◽  
pp. S348
Author(s):  
Megumi Kawamoto ◽  
Yoshiyuki Sano ◽  
Yoshitaka Zenke ◽  
Kenji Kawasumi ◽  
Hiroki Izumi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Clinical Experience ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Tumour Lysis Syndrome ◽  
Small Cell Lung ◽  
Extensive Disease ◽  
Tumour Lysis

scholarly journals Steroid-induced tumour lysis syndrome in small-cell lung cancer

2017 ◽  
Vol 2017 (5) ◽  
Author(s):  
Fasihul Khan ◽  
Shazeen Ayub ◽  
Qurrat Mehmood ◽  
Syed Fayyaz Hussain
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Tumour Lysis Syndrome ◽  
Small Cell Lung ◽  
Tumour Lysis

scholarly journals Spontaneous tumour lysis syndrome in small cell lung cancer: a rare phenomenon

2018 ◽  
pp. bcr-2018-224512 ◽  
Author(s):  
Prajwal Dhakal ◽  
Manoj P Rai ◽  
Modina Thrasher ◽  
Mukta Sharma
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Tumour Lysis Syndrome ◽  
Small Cell Lung ◽  
Tumour Lysis ◽  
Rare Phenomenon

scholarly journals History of Extensive Disease Small Cell Lung Cancer Treatment: Time to Raise the Bar? A Review of the Literature

Cancers ◽  
2021 ◽  
Vol 13 (5) ◽  
pp. 998
Author(s):  
Chiara Lazzari ◽  
Aurora Mirabile ◽  
Alessandra Bulotta ◽  
Maria Grazia Viganó ◽  
Francesca Rita Ogliari ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Treatment Time ◽  
Small Cell ◽  
Review Of The Literature ◽  
Small Cell Lung ◽  
Extensive Disease ◽  
History Of ◽  
Line Standard

Several trials have tried for decades to improve the outcome of extensive disease small cell lung cancer (ED-SCLC) through attempts to modify the standard treatments. Nevertheless, platinum/etoposide combination and topotecan have remained respectively the first and the second line standard treatments for the last 40 years. With the advent of immunotherapy, this scenario has finally changed. Our review aims to provide an overview of the primary studies on the actual therapeutic strategies available for ED-SCLC patients, and to highlight emerging evidence supporting the use of immunotherapy in SCLC patients.

Clinical experience: Stereotactic ablative radiotherapy for non-small cell lung cancer and lung metastases

2013 ◽  
Vol 18 ◽  
pp. S261
Author(s):  
A. Roman Jobacho ◽  
J. Ramirez Ros ◽  
M. Toledo Serrano ◽  
J. Rico Perez ◽  
F. Castillo Montiel ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Clinical Experience ◽  
Cell Lung Cancer ◽  
Lung Metastases ◽  
Small Cell ◽  
Stereotactic Ablative Radiotherapy ◽  
Small Cell Lung

scholarly journals Extensive Disease Small Cell Lung Cancer Dose-Response Relationships: Implications for Resistance Mechanisms

2010 ◽  
Vol 5 (11) ◽  
pp. 1826-1834 ◽  
Author(s):  
David J. Stewart ◽  
Constance Johnson ◽  
Adriana Lopez ◽  
Bonnie Glisson ◽  
Jay M. Rhee ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Dose Response ◽  
Resistance Mechanisms ◽  
Small Cell ◽  
Small Cell Lung ◽  
Extensive Disease
Sign in / Sign up

Export Citation Format

Share Document